Xi-Jing Wang

3.1k total citations
115 papers, 2.2k citations indexed

About

Xi-Jing Wang is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Xi-Jing Wang has authored 115 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Molecular Biology, 31 papers in Oncology and 19 papers in Pharmacology. Recurrent topics in Xi-Jing Wang's work include Cell death mechanisms and regulation (11 papers), Cancer-related Molecular Pathways (10 papers) and Flavonoids in Medical Research (9 papers). Xi-Jing Wang is often cited by papers focused on Cell death mechanisms and regulation (11 papers), Cancer-related Molecular Pathways (10 papers) and Flavonoids in Medical Research (9 papers). Xi-Jing Wang collaborates with scholars based in China, United States and Japan. Xi-Jing Wang's co-authors include Zhijun Dai, Huafeng Kang, Xiaobin Ma, Shuai Lin, Haitao Guan, Weili Min, Xiaoxu Liu, Lingqin Song, Xiaoxu Liu and Xiao‐Mei Kuang and has published in prestigious journals such as Journal of Clinical Oncology, Biochemical and Biophysical Research Communications and International Journal of Molecular Sciences.

In The Last Decade

Xi-Jing Wang

109 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xi-Jing Wang China	28	1.2k	584	404	295	232	115	2.2k
Liwen Ren China	25	1.2k 1.0×	599 1.0×	257 0.6×	88 0.3×	258 1.1×	47	1.9k
Sabu Abraham India	27	1.5k 1.2×	261 0.4×	365 0.9×	145 0.5×	115 0.5×	53	2.5k
Juhua Chen China	21	994 0.8×	257 0.4×	272 0.7×	113 0.4×	146 0.6×	98	2.5k
Alex Lyakhovich Russia	25	1.1k 0.9×	388 0.7×	357 0.9×	45 0.2×	94 0.4×	71	1.7k
Qi Luo China	31	1.2k 1.0×	462 0.8×	390 1.0×	708 2.4×	145 0.6×	140	2.6k
Hiroshi Taguchi Japan	25	1.0k 0.9×	146 0.3×	338 0.8×	75 0.3×	442 1.9×	151	2.2k
Nan Liang China	25	757 0.6×	362 0.6×	176 0.4×	53 0.2×	60 0.3×	79	1.7k
V. Joulin France	29	2.0k 1.7×	594 1.0×	369 0.9×	63 0.2×	134 0.6×	67	3.4k
Hani Zaher United States	29	2.3k 2.0×	187 0.3×	597 1.5×	79 0.3×	29 0.1×	61	3.3k

Countries citing papers authored by Xi-Jing Wang

Since Specialization

Citations

This map shows the geographic impact of Xi-Jing Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xi-Jing Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xi-Jing Wang more than expected).

Fields of papers citing papers by Xi-Jing Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xi-Jing Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xi-Jing Wang. The network helps show where Xi-Jing Wang may publish in the future.

Co-authorship network of co-authors of Xi-Jing Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Xi-Jing Wang. A scholar is included among the top collaborators of Xi-Jing Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xi-Jing Wang. Xi-Jing Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zheng, Jiaqi, et al.. (2025). Genome mining and OSMAC strategies unveil diverse secondary metabolites from the endophytic fungus Diaporthe kyushuensis ZMU-48-1 with antifungal activity. Frontiers in Microbiology. 16. 1604639–1604639. 1 indexed citations

Meng, Yuan, Xiao‐Mei Kuang, Xi-Jing Wang, Bin Wang, & Jian-Pin Wu. (2024). Images of hairy Reissner–Nordström black hole illuminated by static accretions. The European Physical Journal C. 84(3). 21 indexed citations

Wang, Xi-Jing, et al.. (2022). Influenza A (H6N6) viruses isolated from chickens replicate in mice and human lungs without prior adaptation. Journal of Virus Eradication. 8(3). 100086–100086. 5 indexed citations

Hong, Junping, Qian Wang, Qian Wu, et al.. (2021). Rabbit Monoclonal Antibody Specifically Recognizing a Linear Epitope in the RBD of SARS-CoV-2 Spike Protein. Vaccines. 9(8). 829–829. 11 indexed citations

Zhang, Lei, Wen Liu, Fangyan Liu, et al.. (2020). IMCA Induces Ferroptosis Mediated by SLC7A11 through the AMPK/mTOR Pathway in Colorectal Cancer. Oxidative Medicine and Cellular Longevity. 2020. 1–14. 118 indexed citations

Ma, Xiaobin, Chengxue Dang, Weili Min, et al.. (2019). Downregulation of APE1 potentiates breast cancer cells to olaparib by inhibiting PARP-1 expression. Breast Cancer Research and Treatment. 176(1). 109–117. 15 indexed citations

Song, Lingqin, Di Liu, Yang Zhao, et al.. (2018). Sinomenine reduces growth and metastasis of breast cancer cells and improves the survival of tumor-bearing mice through suppressing the SHh pathway. Biomedicine & Pharmacotherapy. 98. 687–693. 26 indexed citations

Wang, Xiaolong, Lei Sun, Xi-Jing Wang, et al.. (2017). Acidified bile acids enhance tumor progression and telomerase activity of gastric cancer in mice dependent on c‐Myc expression. Cancer Medicine. 6(4). 788–797. 32 indexed citations

Ma, Xiaobin, Xi-Jing Wang, Meng Wang, et al.. (2016). Impact of the PARP1 rs1136410 and rs3219145 polymorphisms on susceptibility and clinicopathologic features of breast cancer in a Chinese population. Translational Cancer Research. 5(5). 520–528. 1 indexed citations

10.

Song, Lingqin, Weifeng Wang, Di Liu, et al.. (2016). Targeting of sonic hedgehog-Gli signaling: A potential therapeutic target for patients with breast cancer. Oncology Letters. 12(2). 1027–1033. 18 indexed citations

11.

Dai, Zhijun, Zheng Wang, Xi-Jing Wang, et al.. (2016). Distinct role of the <em>Fas </em>rs1800682 and <em>FasL </em>rs763110 polymorphisms in determining the risk of breast cancer among Han Chinese women. Drug Design Development and Therapy. Volume 10. 2359–2367. 8 indexed citations

12.

Guan, Haitao, Ping Zhao, Zhijun Dai, Xiaoxu Liu, & Xi-Jing Wang. (2016). SH3GL1 inhibition reverses multidrug resistance in colorectal cancer cells by downregulation of MDR1/P-glycoprotein via EGFR/ERK/AP-1 pathway. Tumor Biology. 37(9). 12153–12160. 16 indexed citations

13.

Song, Lingqin, Di Liu, Yang Zhao, et al.. (2015). Sinomenine inhibits breast cancer cell invasion and migration by suppressing NF-κB activation mediated by IL-4/miR-324-5p/CUEDC2 axis. Biochemical and Biophysical Research Communications. 464(3). 705–710. 74 indexed citations

14.

Dai, Zhijun, Xi-Jing Wang, Yang Zhao, et al.. (2014). Effects of Interleukin-10 Polymorphisms (rs1800896, rs1800871, and rs1800872) on Breast Cancer Risk: Evidence from an Updated Meta-Analysis. Genetic Testing and Molecular Biomarkers. 18(6). 439–445. 17 indexed citations

15.

Dai, Zhijun, Jie Gao, An-Jing Kang, et al.. (2014). Association between MDM2 rs 2279744 polymorphism and breast cancer susceptibility: a meta-analysis based on 9,788 cases and 11,195 controls. Therapeutics and Clinical Risk Management. 10. 269–269. 13 indexed citations

16.

Dai, Zhijun, Jie Gao, Huafeng Kang, et al.. (2013). Anti-angiogenic effect of the total flavonoids in Scutellaria barbata D. Don. BMC Complementary and Alternative Medicine. 13(1). 150–150. 39 indexed citations

17.

Gao, Jie, Zhijun Dai, Shuai Lin, et al.. (2013). Induction of apoptosis by total flavonoids from Scutellaria barbata D. Don in human hepatocarcinoma MHCC97-H cells via the mitochondrial pathway. Tumor Biology. 35(3). 2549–2559. 21 indexed citations

18.

Dai, Zhijun, Huafeng Kang, Shuai Lin, et al.. (2013). Esophageal Cancer With Esophageal Duplication Cyst. The Annals of Thoracic Surgery. 96(1). e15–e16. 9 indexed citations

19.

Dai, Zhijun, et al.. (2013). Sonodynamic therapy (SDT): A novel treatment of cancer based on sonosensitizer liposome as a new drug carrier. Medical Hypotheses. 80(3). 300–302. 27 indexed citations

20.

Dai, Zhijun, et al.. (2007). [HER-2 expression in local advanced breast cancer and the efficacy of neoadjuvant chemotherapy regimens].. PubMed. 27(9). 1397–9. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact